£37.11

LAP Lambert Academic Publishing Development and evaluation of film coated tablets of letrozole

Price data last checked 112 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the usual price. Wait for it to drop, or tell us your number.

£37 today · usual range £0–£0 · best ever £32

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 619 days • 619 data points (No recent data available)

Historical
Generating forecast...
£45.57 £30.96 £34.15 £37.34 £40.52 £43.71 £46.90 07 July 2024 08 December 2024 12 May 2025 13 October 2025 17 March 2026

Price Distribution

Price distribution over 619 days • 5 price ranges

Days at Price
Current Price
76 days 15 days · current 11 days 200 days 317 days 0 79 159 238 317 £32-35 £35-38 £38-40 £40-43 £43-46 Days at Price

Price Analysis

Most common range: £43-46 (317 days, 51.2%)

Price range: £32 - £46

Price levels: 5 price ranges over 619 days

Description

The study is an attempt towards developing a formulation of an anti-estrogen drug, which belongs to non-steroidal aromatase inhibitor and which has in-vitro dissolution profile similar to that of reference product. Our target is to develop a dosage form similar to reference product for generic drug application to abbreviated new drug application (ANDA). Immediate drug delivery is required to alter the pharmacokinetics and pharmacodynamics of pharmacological active moieties by using physiological parameters inherent in the selected route of administration. It is also desirable to show rapid onset of action. In case of patient needing a quick action, conventional tablets are unable to release medicament rapidly. The drugs having long half-life and more bioavailability are beneficial for the formulation of immediate release dosage forms. Therefore, the present project involves the development of a formula for an orally administrable immediate release tablet of an anti-estrogen drug, letrozole which must be stable, bio-equivalent to reference listed drug product and has a reproducible and robust process of medication to prevent breast cancer relapse.

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

Raloxifene immediate release tablet for post-menopausal osteoporosis: Formulation development and evaluation of immediate release tablet of estrogen receptor modulator drug
95% match

Raloxifene immediate release tablet for post-menopausal osteoporosis: Formulation development and evaluation of immediate release tablet of estrogen receptor modulator drug

LAP Lambert Academic Publishing

£56.83 17 Mar 2026
Hormone Therapy in Breast and Prostate Cancer (Cancer Drug Discovery and Development)
95% match

Hormone Therapy in Breast and Prostate Cancer (Cancer Drug Discovery and Development)

Humana

£60.74 10 Mar 2026
Resistance to Aromatase Inhibitors in Breast Cancer: 8 (Resistance to Targeted Anti-Cancer Therapeutics, 8)
94% match

Resistance to Aromatase Inhibitors in Breast Cancer: 8 (Resistance to Targeted Anti-Cancer Therapeutics, 8)

Springer

£60.65 16 Mar 2026
Selective Estrogen Receptor Modulators: A New Brand of Multitarget Drugs
94% match

Selective Estrogen Receptor Modulators: A New Brand of Multitarget Drugs

Springer

£30.49 09 Mar 2026
Aromatase Inhibitors (Milestones in Drug Therapy)
94% match

Aromatase Inhibitors (Milestones in Drug Therapy)

Birkhauser

£81.94 04 Jul 2026
Springer - Therapeutic Resistance to Anti-hormonal Drugs Book
94% match

Springer - Therapeutic Resistance to Anti-hormonal Drugs Book

Springer

£113.78 14 Apr 2026
Estrogens and Antiestrogens II: Pharmacology and Clinical Application of Estrogens and Antiestrogen: 135 / 2 (Handbook of Experimental Pharmacology, 135 / 2)
94% match

Estrogens and Antiestrogens II: Pharmacology and Clinical Application of Estrogens and Antiestrogen: 135 / 2 (Handbook of Experimental Pharmacology, 135 / 2)

Springer

£72.05 08 Mar 2026
ESTROGEN PREVENTION FOR BREAST (Cancer Etiology, Diagnosis and Treatments)
94% match

ESTROGEN PREVENTION FOR BREAST (Cancer Etiology, Diagnosis and Treatments)

£75.68 01 Jul 2026
Optimizing Breast Cancer Management: 173 (Cancer Treatment and Research, 173)
93% match

Optimizing Breast Cancer Management: 173 (Cancer Treatment and Research, 173)

Springer

£52.63 03 Jul 2026
Molecular Therapy of Breast Cancer: Classicism Meets Modernity (Cancer Etiology, Diagnosis and Treatments Series)
93% match

Molecular Therapy of Breast Cancer: Classicism Meets Modernity (Cancer Etiology, Diagnosis and Treatments Series)

£54.26 02 Jul 2026
Biologie und Epidemiologie der Hormonersatztherapie - Biology and Epidemiology of Hormone Replacement Therapy: Diskussionen zur Postmenopausalen ... Foundation Symposium Proceedings, 13)
93% match

Biologie und Epidemiologie der Hormonersatztherapie - Biology and Epidemiology of Hormone Replacement Therapy: Diskussionen zur Postmenopausalen ... Foundation Symposium Proceedings, 13)

Springer

£57.97 08 Mar 2026
Endocrine Therapy of Breast Cancer V (ESO Monographs)
93% match

Endocrine Therapy of Breast Cancer V (ESO Monographs)

Springer

£77.82 07 Jul 2026
Estrogen Receptor and Breast Cancer: Celebrating the 60th Anniversary of the Discovery of ER (Cancer Drug Discovery and Development)
93% match

Estrogen Receptor and Breast Cancer: Celebrating the 60th Anniversary of the Discovery of ER (Cancer Drug Discovery and Development)

Humana

£123.47 18 Jun 2026
Precision Molecular Pathology of Breast Cancer: 10 (Molecular Pathology Library, 10)
93% match

Precision Molecular Pathology of Breast Cancer: 10 (Molecular Pathology Library, 10)

Springer

£78.84 06 Mar 2026
Research Progress in Cancer Prevention
93% match

Research Progress in Cancer Prevention

£19.21 08 Mar 2026
Advancing Development of Synthetic Gene Regulators: With the Power of High-Throughput Sequencing in Chemical Biology (Springer Theses)
93% match

Advancing Development of Synthetic Gene Regulators: With the Power of High-Throughput Sequencing in Chemical Biology (Springer Theses)

Springer

£75.84 10 Mar 2026
TAMOXIFEN CONCEPTS CANCER: New Paradigms (Cancer Etiology, Diagnosis and Treatments: Pharmacology - Research, Safety Testing and Regulation)
93% match

TAMOXIFEN CONCEPTS CANCER: New Paradigms (Cancer Etiology, Diagnosis and Treatments: Pharmacology - Research, Safety Testing and Regulation)

£98.75 06 Jul 2026
Clinical Chemistry Research - Nova Science Publishers Book
93% match

Clinical Chemistry Research - Nova Science Publishers Book

£12.05 06 Jul 2026
Translational Research in Breast Cancer: 1187 (Advances in Experimental Medicine and Biology, 1187)
93% match

Translational Research in Breast Cancer: 1187 (Advances in Experimental Medicine and Biology, 1187)

Springer

£131.75 13 Apr 2026
Springer - New Molecular Mechanisms of Estrogen Action (Vol 46)
93% match

Springer - New Molecular Mechanisms of Estrogen Action (Vol 46)

Springer

£121.49 20 Apr 2026
Non–Reproductive Actions of Sex Steroids: No. 191 (Novartis Foundation Symposia)
93% match

Non–Reproductive Actions of Sex Steroids: No. 191 (Novartis Foundation Symposia)

Wiley-Blackwell

£90.00 09 Mar 2026